J. Adam Willardsen

977 total citations
22 papers, 712 citations indexed

About

J. Adam Willardsen is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, J. Adam Willardsen has authored 22 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in J. Adam Willardsen's work include Quinazolinone synthesis and applications (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Microbial Natural Products and Biosynthesis (3 papers). J. Adam Willardsen is often cited by papers focused on Quinazolinone synthesis and applications (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Microbial Natural Products and Biosynthesis (3 papers). J. Adam Willardsen collaborates with scholars based in United States, Germany and Sweden. J. Adam Willardsen's co-authors include Anthony G. M. Barrett, M. R. PENA, Mark Anderson, Kirill Ostanin, Songchun Jiang, Ben Tseng, Christopher M. Pleiman, Nilantha Sirisoma, Gary Mather and Shailaja Kasibhatla and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

J. Adam Willardsen

22 papers receiving 674 citations

Peers

Countries citing papers authored by J. Adam Willardsen

Since Specialization

Citations

This map shows the geographic impact of J. Adam Willardsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Adam Willardsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Adam Willardsen more than expected).

Fields of papers citing papers by J. Adam Willardsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Adam Willardsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Adam Willardsen. The network helps show where J. Adam Willardsen may publish in the future.

Co-authorship network of co-authors of J. Adam Willardsen

This figure shows the co-authorship network connecting the top 25 collaborators of J. Adam Willardsen. A scholar is included among the top collaborators of J. Adam Willardsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Adam Willardsen. J. Adam Willardsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis of Substituted Quinazolines: Application to the Synthesis of Verubulin 2012 ·Synthetic Communications ·Jeffrey W. Lockman, (unknown), Mark Anderson, J. Adam Willardsen	11
2	Oxindole derivatives as inhibitors of TAK1 kinase 2011 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Lockman, (unknown), Rosann Robinson, Patricia A. Ormonde, Daniel Cimbora, Brandi L. Williams, J. Adam Willardsen	24
3	Activity of the cancer metabolism inhibitor MPC-9528 in xenograft models: Comparison of different dosing schedules. 2011 ·Journal of Clinical Oncology ·Vijay Baichwal, J. Adam Willardsen, Jeffrey W. Lockman, (unknown), Ruth Gordillo, Tracey C. Fleischer, Chad Bradford, Damon I. Papac, Gary Mather, Robert Carlson	1
4	Discovery of N-methyl-4-(4-methoxyanilino)quinazolines as potent apoptosis inducers. Structure–activity relationship of the quinazoline ring 2010 ·Bioorganic & Medicinal Chemistry Letters ·Nilantha Sirisoma, Azra Pervin, Hong Zhang, Songchun Jiang, J. Adam Willardsen, Mark Anderson, Gary Mather, Christopher M. Pleiman, Shailaja Kasibhatla, Ben Tseng, John Drewe, Sui Xiong Cai	44
5	Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Lockman, (unknown), Kazuyuki Suzuki, Kirill Ostanin, (unknown), (unknown), (unknown), Vijay Baichwal, J. Adam Willardsen	56
6	Chemical Proteomics Identifies Nampt as the Target of CB30865, An Orphan Cytotoxic Compound 2010 ·Chemistry & Biology ·Tracey C. Fleischer, (unknown), Jeffrey S. Flick, Ryan T. Terry-Lorenzo, (unknown), Thaylon Davis, Rena McKinnon, Kirill Ostanin, J. Adam Willardsen, J. Jay Boniface	44
7	Analogues of 4-[(7-Bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methylprop-2-ynylamino]-N-(3-pyridylmethyl)benzamide (CB-30865) as Potent Inhibitors of Nicotinamide Phosphoribosyltransferase (Nampt) 2010 ·Journal of Medicinal Chemistry ·Jeffrey W. Lockman, (unknown), (unknown), (unknown), (unknown), (unknown), Kirill Ostanin, Jeremy Green, Rena McKinnon, Ryan T. Terry-Lorenzo, Tracey C. Fleischer, J. Jay Boniface, Mark D. Shenderovich, J. Adam Willardsen	20
8	2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97) 2010 ·Bioorganic & Medicinal Chemistry Letters ·Matthew G. Bursavich, (unknown), J. Adam Willardsen, Zhong‐Hua Gao, Thaylon Davis, Kirill Ostanin, Rosann Robinson, Ashley Peterson, Daniel Cimbora, (unknown), Burt T. Richards	49
9	Abstract LB-288: MPI-0486348: A novel inhibitor of nicotinamide phosphoribosyltransferase (Nampt) induces tumor regression in a preclinical model 2010 ·Cancer Research ·Tracey C. Fleischer, Vijay Baichwal, Chad Bradford, (unknown), (unknown), Mark A. Hess, Jeffrey W. Lockman, Rena McKinnon, Kirill Ostanin, Damon I. Papac, (unknown), Ryan T. Terry-Lorenzo, J. Adam Willardsen	2
10	Abstract #LB-204: MPI-0479605: A novel small molecule inhibitor of the mitotic kinase TTK with anti-tumor activity in pre-clinical models 2009 ·Cancer Research ·Brandi L. Williams, Daniel Cimbora, Vijay Baichwal, Damon I. Papac, (unknown), J. Adam Willardsen, Dhiraj Kumar	1
11	Discovery of N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration 2009 ·Journal of Medicinal Chemistry ·Nilantha Sirisoma, Azra Pervin, Hong Zhang, Songchun Jiang, J. Adam Willardsen, Mark Anderson, Gary Mather, Christopher M. Pleiman, Shailaja Kasibhatla, Ben Tseng, John Drewe, Sui Xiong Cai	107
12	Anticancer Agents: VTA or VDA 2009 ·Current Bioactive Compounds ·Paul R. Sebahar, J. Adam Willardsen, Mark Anderson	8
13	Discovery of 2-Chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a Potent Inducer of Apoptosis with High In Vivo Activity 2008 ·Journal of Medicinal Chemistry ·Nilantha Sirisoma, Shailaja Kasibhatla, Azra Pervin, Hong Zhang, Songchun Jiang, J. Adam Willardsen, Mark Anderson, Vijay Baichwal, Gary Mather, (unknown), Raouf A. Hussain, (unknown), Christopher M. Pleiman, Ben Tseng, John Drewe, Sui Xiong Cai	63
14	Protease-Activated Receptor 2, Dipeptidyl Peptidase I, and Proteases Mediate Clostridium difficile Toxin A Enteritis 2007 ·Gastroenterology ·Graeme S. Cottrell, Silvia Amadesi, Stella Pikios, Eric Camerer, J. Adam Willardsen, (unknown), George H. Caughey, Paul J. Wolters, Shaun R. Coughlin, Anders Peterson, Wolfgang Knecht, Charalabos Pothoulakis, Nigel W. Bunnett, Eileen F. Grady	44
15	The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex—Part 2 2005 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey T. Kohrt, Kevin J. Filipski, Wayne L. Cody, (unknown), Danette A. Dudley, (unknown), J. Adam Willardsen, Lakshmi Narasimhan, Erli Zhang, Stephen T. Rapundalo, Kamlai Saiya-Cork, Robert J. Leadley, Jeremy J. Edmunds	10
16	Design, Synthesis, and Biological Activity of Potent and Selective Inhibitors of Blood Coagulation Factor Xa 2004 ·Journal of Medicinal Chemistry ·J. Adam Willardsen, Danette A. Dudley, Wayne L. Cody, Liguo Chi, Thomas B. McClanahan, Thomas Mertz, (unknown), Lakshmi Narasimhan, Debra R. Holland, Stephen T. Rapundalo, Jeremy J. Edmunds	107
17	Recent advances in the synthesis of bioactive natural products 1996 ·Journal of Heterocyclic Chemistry ·Anthony G. M. Barrett, Wendel W. Doubleday, (unknown), (unknown), Gary J. Tustin, J. Adam Willardsen	2
18	Total Synthesis and Structural Elucidation of the Antifungal Agent Papulacandin D 1996 ·The Journal of Organic Chemistry ·Anthony G. M. Barrett, M. R. PENA, J. Adam Willardsen	49
19	Total synthesis of the antifungal agent papulacandin D 1995 ·Journal of the Chemical Society Chemical Communications ·Anthony G. M. Barrett, M. R. PENA, J. Adam Willardsen	17
20	Approaches towards the synthesis of papulacandin D: preparation and structural elucidation of the acyl side chain 1995 ·Journal of the Chemical Society Chemical Communications ·Anthony G. M. Barrett, M. R. PENA, J. Adam Willardsen	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact